Expert Talk
Building the Bridge: How B2B Media Is Shaping the Future of Chemical Engineering
The shift is already well underway BB medias value used to be measured in reach how many engineers received your magazine how many clicks your digital content generated What downstream companies
GLP-1 Therapies in Real-World Weight Care: Provider Insights on Adoption, Adherence, and Outcomes
Before GLPs obesity management was neglected There was no real plan or employer focus on obesity GLPs have completely changed that For good and bad never has a drug been demanded by consumers like this The good thing is that there now is a focus on obesity and the upside of treating it properly in terms of improved cardiometabolic outcomes
Single Use Technologies (SUT) in Pharmaceutical Manufacturing
SUT has shifted manufacturing toward speed flexibility and modular capacity By replacing fixed stainless steel
Fundamentals and Design of Drug Delivery Systems
A Textbook with Lab Activities
Most engineering students lack foundational pharmacology knowledge yet advanced drug delivery system design must be
Oligonucleotide CMC & Manufacturing
With the rapid expansion of oligonucleotide therapeutics into formats such as AOCs novel conjugates pegRNAs and multivalent
Microbiome and Microbial Omics Data in Clinical Stages
Exploring the Facts, Fictions, and Bottlenecks
Specifically in microbiome testing there is so much to gain from a fast gotomarket strategy that is the moment you start capturing
Strategic Visibility
How Media Partnerships Are Redefining B2B Pharma Events
Pharma events have transitioned from being standalone networking opportunities to becoming strategic industry platforms
How AI is Reshaping Compliance and Quality Management in the Life Sciences Sector in 2025
AI is shifting the role of quality professionals from messengers to datadriven decisionmakers Traditionally
Clinical Trial Modernization
Technological, Operational, and Regulatory Advances
The transformation of clinical trials is driven by a convergence of operational inefficiencies technological
RNA, CAR-T & CRISPR
Engineering the Next Frontier of Medicine
CART has matured with approvals reimbursement and expanding use but now its optimizing not reinventing
